Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study
Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the Study is to determine whether early treatment with pravastatin can reduce
adverse cardiac events in patients with acute myocardial infarction and minimally to mildly
elevated serum Low Density Lipoprotein -Cholesterol (LDL-C) levels.